AWM Investment Company Inc. Buys 28,488 Shares of OrthoPediatrics Corp. $KIDS

AWM Investment Company Inc. increased its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 5.5% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 545,282 shares of the company’s stock after acquiring an additional 28,488 shares during the quarter. OrthoPediatrics accounts for approximately 1.8% of AWM Investment Company Inc.’s portfolio, making the stock its 20th largest position. AWM Investment Company Inc. owned approximately 2.25% of OrthoPediatrics worth $13,430,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. GAMMA Investing LLC increased its stake in shares of OrthoPediatrics by 4,618.2% in the 1st quarter. GAMMA Investing LLC now owns 10,616 shares of the company’s stock valued at $261,000 after acquiring an additional 10,391 shares in the last quarter. SG Americas Securities LLC increased its stake in shares of OrthoPediatrics by 175.0% in the 1st quarter. SG Americas Securities LLC now owns 20,039 shares of the company’s stock valued at $494,000 after acquiring an additional 12,753 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of OrthoPediatrics by 29.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock valued at $15,576,000 after acquiring an additional 152,681 shares in the last quarter. Deutsche Bank AG grew its position in OrthoPediatrics by 57.1% in the 4th quarter. Deutsche Bank AG now owns 14,393 shares of the company’s stock valued at $334,000 after purchasing an additional 5,233 shares during the period. Finally, Barclays PLC grew its position in OrthoPediatrics by 12.2% in the 4th quarter. Barclays PLC now owns 28,390 shares of the company’s stock valued at $658,000 after purchasing an additional 3,092 shares during the period. Institutional investors own 69.05% of the company’s stock.

Insider Transactions at OrthoPediatrics

In other news, CFO Fred Hite acquired 5,076 shares of the stock in a transaction that occurred on Thursday, August 21st. The shares were acquired at an average cost of $19.41 per share, for a total transaction of $98,525.16. Following the purchase, the chief financial officer owned 213,065 shares of the company’s stock, valued at approximately $4,135,591.65. The trade was a 2.44% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 31.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on KIDS. Piper Sandler cut their price objective on shares of OrthoPediatrics from $40.00 to $30.00 and set an “overweight” rating on the stock in a report on Thursday, May 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a report on Thursday, May 8th. BTIG Research cut their price objective on shares of OrthoPediatrics from $40.00 to $39.00 and set a “buy” rating on the stock in a report on Wednesday, August 6th. Wall Street Zen raised shares of OrthoPediatrics from a “sell” rating to a “hold” rating in a report on Saturday, August 9th. Finally, JMP Securities set a $35.00 price target on shares of OrthoPediatrics and gave the stock a “market outperform” rating in a report on Friday, August 8th. Seven investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $34.14.

OrthoPediatrics Trading Down 2.6%

Shares of OrthoPediatrics stock opened at $20.80 on Wednesday. OrthoPediatrics Corp. has a 52-week low of $16.59 and a 52-week high of $33.14. The stock’s 50-day simple moving average is $21.14 and its 200 day simple moving average is $22.06. The stock has a market capitalization of $521.46 million, a P/E ratio of -11.62 and a beta of 1.06. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.43 and a current ratio of 6.66.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.17) by $0.06. OrthoPediatrics had a negative return on equity of 6.36% and a negative net margin of 18.92%.The business had revenue of $61.08 million for the quarter, compared to analysts’ expectations of $61.40 million. OrthoPediatrics has set its FY 2025 guidance at EPS. As a group, research analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.